The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finkelman, F. D.
Right arrow Articles by Katona, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finkelman, F. D.
Right arrow Articles by Katona, I. M.

The Journal of Immunology, Vol 142, Issue 2 403-408, Copyright © 1989 by American Association of Immunologists


ARTICLES

T help requirements for the generation of an in vivo IgE response: a late acting form of T cell help other than IL-4 is required for IgE but not for IgG1 production

FD Finkelman, J Holmes, JF Urban Jr, WE Paul and IM Katona
Department of Medicine, Uniformed Services, University of the Health Sciences, Bethesda, MD 20814.

To further define requirements for T cell help in the stimulation of an in vivo IgE response, we studied a system in which the injection of mice with a goat antibody to mouse IgD (GaMD) stimulates large polyclonal IgG1 and IgE responses. In this system, both responses are blocked by anti-CD4 antibody, but only the IgE response is blocked by (anti-IL-4) antibody. Anti-CD4 antibody, if injected 5 days after GaMD, was found to inhibit the GaMD-induced IgE response to a much greater extent than the IgG1 response, even though both responses occur simultaneously and are inhibited to an equal extent by optimal or suboptimal doses of anti-CD4 antibody administered 2 days after GaMD. Even a suboptimal, 50-micrograms dose of anti-CD4 antibody, when injected 5 days after GaMD, inhibited the IgE response to a much greater extent than did an optimal 10-mg dose of anti-IL-4 antibody injected at the same time, even though 10 mg of anti-IL-4 antibody more completely inhibited GaMD-induced IgE production than did 50 micrograms of anti-CD4 antibody when injected 2 days after GaMD. These observations provide evidence that a late acting form of T cell help other than IL-4 is important for the generation of an IgE response but not an IgG1 response in GaMD-immunized mice.


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
M. V. Khodoun, T. Orekhova, C. Potter, S. Morris, and F. D. Finkelman
Basophils Initiate IL-4 Production during a Memory T-dependent Response
J. Exp. Med., October 4, 2004; 200(7): 857 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. R. Mathers and C. F. Cuff
Role of Interleukin-4 (IL-4) and IL-10 in Serum Immunoglobulin G Antibody Responses following Mucosal or Systemic Reovirus Infection
J. Virol., April 1, 2004; 78(7): 3352 - 3360.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Ekkens, Z. Liu, Q. Liu, A. Foster, J. Whitmire, J. Pesce, A. H. Sharpe, J. F. Urban, and W. C. Gause
Memory Th2 Effector Cells Can Develop in the Absence of B7-1/B7-2, CD28 Interactions, and Effector Th Cells After Priming with an Intestinal Nematode Parasite
J. Immunol., June 15, 2002; 168(12): 6344 - 6351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. Morris, W. C. Gause, and F. D. Finkelman
IL-4 Suppression of In Vivo T Cell Activation and Antibody Production
J. Immunol., February 15, 2000; 164(4): 1734 - 1740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Levine, S. H. Rangwala, M. A. Peel, R. M. Leimgruber, J. A. Manning, B. F. Bishop, and P. O. Olins
High Level Expression and Refolding of Mouse Interleukin 4 Synthesized in Escherichia coli
J. Biol. Chem., March 31, 1995; 270(13): 7445 - 7452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.